XML 27 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities      
Net loss $ (36,933) $ (13,421) $ (27,236)
Adjustments to reconcile net loss to net cash used in operating activities      
Depreciation of property and equipment 3,687 3,096 2,945
Amortization of intangible assets 1,342 1,216 1,234
Charges incurred in connection with acquired IPR&D 0 3,353 0
Provision for doubtful accounts 150 0 1,300
Write-off of patent costs 0 0 4,206
Stock-based compensation 17,841 16,230 13,612
Accretion (Amortization) of Discounts and Premiums, Investments 1,240 1,432 (109)
Other (391) 268 170
Changes in assets and liabilities      
Accounts receivable 205 (14,821) 9,503
Inventories (2,254) (4,607) (9,648)
Prepaid expenses and other assets (1,271) (1,962) 1,319
Accounts payable 677 2,073 576
Accrued expenses and other liabilities (6,078) 8,239 (8,906)
Deferred revenue (2,487) (1,980) (1,731)
Net cash used in operating activities (24,272) (884) (12,765)
Cash flows from investing activities      
Expenditures for property and equipment (4,220) (3,954) (3,369)
Acquisitions (1,700) (3,353) (5,741)
Purchases of long-term investments (12,340) (14,404) (750)
Purchases of marketable securities (111,983) (199,138) (38,782)
Sales of marketable securities 15,792 6,885 7,290
Maturities of marketable securities 136,612 101,255 33,400
Costs incurred in connection with patents 0 0 (717)
Net cash provided by (used in) investing activities 22,161 (112,709) (8,669)
Cash flows from financing activities      
Proceeds from the employee stock purchase plan 3,042 4,238 4,076
Payment of employee taxes related to vested restricted stock (5,367) (4,884) (6,303)
Exercise of stock options 12 0 0
Proceeds from offering of common stock 0 0 134,979
Principal payments made on financing obligation (222) (154) (92)
Net cash (used in) provided by financing activities (2,535) (800) 132,660
Net change in cash and cash equivalents (4,646) (114,393) 111,226
Cash and cash equivalents      
Beginning of period 71,070 185,463 74,237
End of period 66,424 71,070 185,463
Supplemental cash flow information      
Interest paid $ 1,634 $ 1,649 $ 1,659